Onconetix Faces Delisting Concerns
Ticker: ONCO · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1782107
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Onconetix might get delisted, check their listing status.
AI Summary
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) filed an 8-K on April 18, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's principal executive offices are located at 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio, 45202.
Why It Matters
This filing indicates potential issues with Onconetix, Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's trading viability and investor confidence.
Key Players & Entities
- Onconetix, Inc. (company) — Registrant
- Blue Water Biotech, Inc. (company) — Former company name
- April 14, 2025 (date) — Earliest event reported
- April 18, 2025 (date) — Filing date
- 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio, 45202 (address) — Principal Executive Offices
FAQ
What specific listing rule or standard has Onconetix, Inc. failed to satisfy?
The filing does not specify the exact listing rule or standard that Onconetix, Inc. has failed to satisfy, only that a notice has been issued.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated April 14, 2025.
What was Onconetix, Inc. previously known as?
Onconetix, Inc. was formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc.
Where are Onconetix, Inc.'s principal executive offices located?
The principal executive offices are located at 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio, 45202.
What is the Commission File Number for Onconetix, Inc.?
The Commission File Number for Onconetix, Inc. is 001-41294.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding Onconetix, Inc. (ONCO).